Intranasal Analgesia for Veterinary and Aquatic Applications

The inventive concept extends the core technology of preservative-free intranasal lidocaine compositions to treat pain and discomfort in veterinary and aquatic applications, providing a rapid onset of analgesia and alleviating stress in animals.

The original patent disclosed a preservative-free intranasal composition for treating pain associated with trigeminal neuralgia, facial neuropathic pain, and other human conditions. However, there is a need for effective and safe analgesic solutions in veterinary and aquatic medicine, where current treatments often have limited efficacy or undesirable side effects. The new inventive concept addresses this gap by adapting the core technology to address pain and discomfort in animals, improving their welfare and quality of life.

The inventive concept comprises a preservative-free intranasal composition of lidocaine in a multi-dose spray container, administered to animals via a mechanical pump device. The composition provides a rapid onset of analgesia, alleviating pain and discomfort associated with various veterinary and aquatic conditions, such as respiratory diseases in livestock, stress in poultry, dental procedures in companion animals, exercise-induced muscle soreness in horses, and aquatic animal husbandry. The mechanical pump device ensures accurate dosing and minimizes waste, while the preservative-free composition reduces the risk of adverse reactions and promotes animal safety.

The new inventive concept is novel and non-obvious in its application of preservative-free intranasal lidocaine compositions to veterinary and aquatic medicine, providing a unique solution for pain management in animals. The inventive step lies in the adaptation of the core technology to address specific challenges and needs in these industries, demonstrating a new and unexpected use of the original patent's composition and device.

Alternative embodiments of the inventive concept could include variations in the composition, such as different concentrations of lidocaine or the addition of other analgesic agents. The mechanical pump device could also be modified to accommodate different animal species or sizes. Furthermore, the inventive concept could be integrated with other veterinary or aquatic medical devices, such as inhalers or injectors, to provide a comprehensive pain management solution.

The inventive concept has significant commercial potential in the veterinary and aquatic medicine markets, where there is a growing demand for effective and safe analgesic solutions. The market for veterinary pain management is projected to grow at a CAGR of 8% from 2023 to 2028, driven by increasing pet ownership and advances in veterinary care. The inventive concept could also find applications in aquatic animal husbandry, where pain management is critical for animal welfare and productivity. The target industries include veterinary pharmaceutical companies, animal health organizations, and aquatic animal husbandry operations.